Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676598 · ClinicalTrials.gov registry record
A Prospective Analysis of the Effect of Therapeutic Hypothermia After Cardiac Arrest
A clinical trial of Cardiac Arrest, sponsored by Advocate Hospital System.
- Completed
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT00676598: Completed study of Cardiac Arrest, sponsored by Advocate Hospital System.
NCT00676598 is a study of Cardiac Arrest that has completed, run by Advocate Hospital System. The registered enrollment target is 70 participants, below the 1,478-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00676598, a study of Cardiac Arrest, has completed, sponsored by Advocate Hospital System.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Therapeutic hypothermia has been shown to improve survival and neurologic outcome in patients resuscitated after ventricular fibrillation arrest. Few studies have examined whether therapeutic hypothermia is effective outside the research setting, or with other presenting rhythms. Our institution, a large community teaching hospital, instituted a therapeutic hypothermia protocol in November 2006 for all resuscitated cardiac arrest patients. The investigators seek to determine the mortality rate of our protocol and compare our complication rates with those of previously published studies.
Conditions Studied
Study Locations (1)
Illinois
- Adcovate Christ Hospital - Oak Lawn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-12 |
What the finished NCT00676598 record still lists
NCT00676598 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,478-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Cardiac Arrest appearing as the primary indexed condition, and to 0 interventions.
NCT00676598 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00676598 about?
NCT00676598 is a clinical study titled "A Prospective Analysis of the Effect of Therapeutic Hypothermia After Cardiac Arrest". Therapeutic hypothermia has been shown to improve survival and neurologic outcome in patients resuscitated after ventricular fibrillation arrest. Few studies have examined whether therapeutic hypothermia is effective outside the research setting, or with other presenting rhythms. Our institution, ...
What is the current status of trial NCT00676598?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2007-01. Estimated completion is 2010-12.
What conditions does trial NCT00676598 study?
This clinical trial studies the following conditions: Cardiac Arrest.
Who is sponsoring clinical trial NCT00676598?
This trial is sponsored by Advocate Hospital System, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00676598 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00676598's enrollment target sits among peer trials
70 18th of 31 higher than 14 of 31 other Cardiac Arrest trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Arrest trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Amiodarone in Shockable Cardiac Arrest
RECRUITING · Phase 3
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Post-CA Neuroprotection With Magnesium
RECRUITING · Phase 1
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Resuscitative TEE Collaborative Registry
RECRUITING
-
Hydrogen's Feasibility and Safety as a Therapy in ECPR
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia